Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of an Acellular Osteochondral Graft for Cartilage LEsions Pilot Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 21 years old and skeletally mature~* KOOS Pain subscale score is less than 65 (i.e. moderate pain)~* KOOS Activities of Daily Living score is less than 70 (i.e. moderate functional limitations)~* ICRS grade 3 or 4 cartilage lesion on the medial femoral condyle, lateral femoral condyle or trochlea measuring less than or equal to 15mm in diameter~* Stable meniscus with greater than 50% remaining bilaterally~* Mental capacity and willingness to comply with the post-operative rehabilitation plan and follow-up evaluations~* Written informed consent~Exclusion Criteria:~* Body mass index greater than 35~* Contraindication for MRI~* Previous microfracture, autograft implantation, allograft implantation or autologous chondrocyte implantation procedure on the damaged cartilage surface~* Knee ligament surgery within the past 6 months~* Clinically significant knee malalignment~* Osteoarthritis in the knee~* Multiple cartilage lesions~* Inflammatory arthropathy (i.e. rheumatoid arthritis, systemic lupus or active gout)~* Active infection in either lower limb~* Hyaluronic acid or cortisone injections within the past 3 months~* History of substance abuse~* Current participation in a study of an investigational product for a similar purpose~* Active litigation for the knee injury

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment (Type: EXPERIMENTAL): Patients assigned to the treatment arm will receive treatment with the Kensey Nash Corp. Cartilage Repair Device.
- Control (Type: ACTIVE_COMPARATOR): Patients assigned to the Control Arm will receive treatment with the standard surgical technique known as microfracture.

Based on this trial design, predict the completion outcome and termination type (if applicable).